Unilever and the World Heart Federation announce a joint initiative to promote awareness of Heart Age - a new, personally motivating way of expressing an individual's risk of developing heart disease and stroke. At a global media launch, leading worldwide cardiovascular disease (CVD) experts - including Professor Pekka Puska (President, World Heart Federation) and Professor Rod Jackson (Head of Clinical Epidemiology & Biostatistics, University of Auckland) - pledged their support for the new concept, which they believe could help in the global effort to reduce CVD, the leading cause of premature death worldwide. Heart Age, based on the well-established and highly respected Framingham Risk Score, uses standard risk factors for heart disease or stroke (such as age, weight, gender, cholesterol, blood pressure and smoking) to estimate a person's 'Heart Age', which could be higher than their chronological age if their personal CVD risk factors are high.
Researchers at the Harold Hamm Oklahoma Diabetes Center have found a way to stop the damage caused by Type 1 diabetes with the combination of insulin and a common vitamin found in most medicine cabinets. While neither therapy produced desired results when used alone, the combination of insulin to control blood sugar together with the use of Vitamin C, stopped blood vessel damage caused by the disease in patients with poor glucose control. The findings appear this week in the Journal of Clinical Endocrinology and Metabolism. "We had tested this theory on research models, but this is the first time anyone has shown the therapy's effectiveness in people, " said Michael Ihnat, Ph.
Angina - or angina pectoris (Latin for squeezing of the chest) - is chest pain, discomfort, or tightness that occurs when an area of the heart muscle is receiving decreased blood oxygen supply. It is not a disease itself, but rather a symptom of coronary artery disease, the most common type of heart disease. The lack of oxygen rich blood to the heart is usually a result of narrower coronary arteries due to plaque buildup, a condition called atherosclerosis. Narrow arteries increase the risk of pain, coronary artery disease, heart attack, and death. Angina may manifest itself in the form of an angina attack, pain or discomfort in the chest that typically lasts from 1 to 15 minutes.
Heparin Use Prior To Endoscopic Vein Harvest Improves Graft Patency In Off-Pump Coronary Artery Bypass Patients
MAQUET Cardiovascular LLC announced that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administration of a heparin bolus with doses as low as 2500U prior to endoscopic vein harvest (EVH) was associated with improved acute saphenous vein (SV) graft patency in patients undergoing off-pump coronary artery bypass (OPCAB). Pre-heparinization was also linked to a significant reduction in the incidence and volume of residual clot strands within the vein. In EVH, a small incision is made in the leg, through which an endoscope is passed and the vein harvested for coronary artery bypass graft (CABG) procedures.
The general public will be encouraged to 'Know Your Pulse' by legendary smoothie Sir Roger Moore, as part of Arrhythmia Awareness Week (8-14 June 2009). A new online video brings the quintessential Bond back to screens. Having a heart rhythm problem himself, Sir Roger is taking the opportunity to encourage the public to 'Know Your Pulse' as an important diagnostic of a potentially fatal heart rhythm. Cardiac arrhythmia is the UK's No. 1 killer, with 100, 000 people dying every year from sudden cardiac arrest as a result of a lethally fast heart rhythm. Sudden Cardiac Arrests, caused by arrhythmias, lead to more deaths than breast cancer, lung cancer and AIDS combined.
Four leading patient and medical associations announced the formation of AF AWARE (Atrial Fibrillation AWareness And Risk Education), a joint initiative to highlight and address issues that contribute to the growing burden of atrial fibrillation (AF) worldwide. AF is a common yet under-recognised and poorly understood abnormal heart rhythm that is associated with poor quality of life, substantial numbers of hospitalisations, increased risk of severe and potentially fatal cardiovascular complications such as stroke, as well as death. Marking the start of World Heart Rhythm Week, the World Heart Federation (WHF), Atrial Fibrillation Association (AFA), Stroke Alliance For Europe (SAFE), and European Heart Rhythm Association (EHRA) have come together to call upon their peers around the world to raise awareness and understanding of AF and its cardiovascular consequences.